Assessment of the safety and gut microbiota modulation ability of an infant formula containing Bifidobacterium animalis ssp. lactis CP-9 or Lactobacillus salivarius AP-32 and the effects of the formula on infant growth outcomes: insights from a four-month clinical study in infants under two months old
评估含有动物双歧杆菌乳亚种CP-9或唾液乳杆菌AP-32的婴儿配方奶粉的安全性和肠道菌群调节能力，以及该配方奶粉对婴儿生长发育的影响：一项针对两个月以下婴儿的为期四个月的临床研究的启示
期刊:BMC Pediatrics
影响因子:2
doi:10.1186/s12887-024-05289-7
Shen, Shang-Po; Lin, Hung-Chih; Chen, Jui-Fen; Wang, Hui-Shan; Huang, Yen-Yu; Hsia, Ko-Chiang; Lin, Jia-Hung; Kuo, Yi-Wei; Li, Ching-Min; Hsu, Yu-Chieh; Tsai, Shin-Yu; Ho, Hsieh-Hsun
